Yingying Ma
Jinfeng, 401329, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Transcriptomics-based multi-omics approach for optimizing risk stratification in acute myeloid leukemia.
Journal: Blood science (Baltimore, Md.)
Published: January 27, 2026
Recent advances in CAR-MSCs: the new engine of cellular immunotherapy evolution.
Journal: Journal of hematology & oncology
Published: July 02, 2025
Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed/refractory AML: preclinical evaluation and phase I trial.
Journal: Experimental hematology & oncology
Published: November 05, 2024
Long-term survival with donor CD19 CAR-T cell treatment for relapsed patients after allogeneic hematopietic stem cell transplantation.
Journal: Journal of hematology & oncology
Published: September 11, 2024
Frailty and mortality among patients with chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis.
Journal: International urology and nephrology
Published: September 19, 2019
Treatment Selection for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors.
Journal: Chemotherapy
Published: February 18, 2019
Effect of arsenic trioxide on proliferation and apoptosis of human leukemia cell line MV4-11 cells
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: August 26, 2015
Is allogeneic transplantation really the best treatment for FLT3/ITD-positive acute myeloid leukemia? A systematic review.
Journal: Clinical transplantation
Published: November 25, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026